These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 5171110)
1. Experimental epsilon-aminocaproic acid (EACA) administration in the presence of subarachnoid blood. Ewald T; Mahaley S; Goodrich J; Wilkinson R; Silver D J Neurosurg; 1971 Dec; 35(6):657-63. PubMed ID: 5171110 [No Abstract] [Full Text] [Related]
2. Arteriopathic complications during treatment of subarachnoid hemorrhage with epsilon-aminocaproic acid. Sonntag VK; Stein BM J Neurosurg; 1974 Apr; 40(4):480-5. PubMed ID: 4814379 [No Abstract] [Full Text] [Related]
3. [Letter: Thrombotic complications in cases of subarachnoid hemorrhages treated with epsilon-aminocaproic acid]. Neurol Neurochir Pol; 1976; 10(3):435-6. PubMed ID: 951033 [No Abstract] [Full Text] [Related]
4. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition. Burchiel KJ; Hoffman JM; Bakay RA Neurosurgery; 1984 Jan; 14(1):57-63. PubMed ID: 6537999 [TBL] [Abstract][Full Text] [Related]
5. Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial. Shucart WA; Hussain SK; Cooper PR J Neurosurg; 1980 Jul; 53(1):28-31. PubMed ID: 7411206 [TBL] [Abstract][Full Text] [Related]
13. A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms. Burchiel KJ; Schmer G J Neurosurg; 1981 Jan; 54(1):12-5. PubMed ID: 7463112 [TBL] [Abstract][Full Text] [Related]
14. An experimental study of the influence of antifibrinolytic therapy on post-subarachnoid-hemorrhagic cerebral vasospasm and hydrocephalus. Kenning JA; Heros RC; Dujovny M; Latchaw RE; Nelson D Surg Neurol; 1984 Feb; 21(2):159-64. PubMed ID: 6701753 [TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment. Filizzolo F; D'angelo V; Collice M; Ferrara M; Donati MB; Porta M Eur Neurol; 1978; 17(1):43-7. PubMed ID: 624294 [TBL] [Abstract][Full Text] [Related]
17. Why may epsilon-aminocaproic acid (EACA) induce myopathy in man? Report of a case and literature review. Galassi G; Gibertoni M; Corradini L; Colombo A Ital J Neurol Sci; 1983 Dec; 4(4):489-92. PubMed ID: 6674249 [TBL] [Abstract][Full Text] [Related]
18. Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid hemorrhage. Adams HP Stroke; 1982; 13(2):256-9. PubMed ID: 7039006 [No Abstract] [Full Text] [Related]
19. Epsilon-aminocaproic acid myopathy. Report of a case and literature review. Vanneste JA; van Wijngaarden GK Eur Neurol; 1982; 21(4):242-8. PubMed ID: 7117311 [TBL] [Abstract][Full Text] [Related]